Prospective evaluation of minimal residual disease in multiple myeloma following autologous stem cell transplantation(ASCT) and consolidation therapy.

被引：0
|
作者：
Patekar, Mukesh
Kumar, Lalit
Sharma, Atul
Gupta, Ritu
Vishnubhatla, Sreenivas
Naik, Ramavath Devendra
Pai, Rohit Ramesh
Tiwari, Akash
Dahiya, Meetu
机构：
[1] AIIMS, New Delhi, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi, India
[3] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20033
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Autologous stem cell transplantation in multiple myeloma
    Ricciuti, Giuseppina
    Falcone, Antonietta
    Cascavilla, Nicola
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2020, 62 (04) : 220 - 224
  • [42] Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma
    Lemieux, Emilie
    Hulin, Cyrille
    Caillot, Denis
    Tardy, Stephanie
    Dorvaux, Veronique
    Michel, Jessica
    Gastinne, Thomas
    Rossi, Cedric
    Legouge, Caroline
    Touzeau, Cyrille
    Planche, Lucie
    Loirat, Marion
    Lafon, Ingrid
    Moreau, Philippe
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 445 - 449
  • [43] The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma
    Joks, Monika
    Jurczyszyn, Artur
    Machaczka, Maciej
    Skotnicki, Aleksander B.
    Komarnicki, Mieczyslaw
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (02) : 109 - 114
  • [44] Second autologous stem cell transplant (ASCT) as salvage therapy for relapsed multiple myeloma.
    Olin, RL
    Porter, DL
    Luger, SM
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Glatstein, E
    Siegel, DL
    Vogl, DT
    Mangan, P
    Cunningham, K
    Stadtmauer, EA
    BLOOD, 2005, 106 (11) : 342A - 342A
  • [45] Nonmyeloablative conditioning and allogeneic stem cell transplantation as consolidation therapy after high-dose melphalan and autologous stem cell transplantation for multiple myeloma
    Schneider, P
    Fenk, R
    Bernhard, A
    Huenerlituerkoglu, AN
    Aivado, M
    Wehmeier, A
    Pape, H
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S101 - S101
  • [46] Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
    de Tute, Ruth M.
    Rawstron, Andy C.
    Gregory, Walter M.
    Child, J. Anthony
    Davies, Faith E.
    Bell, Sue E.
    Cook, Gordon
    Szubert, Alexander J.
    Drayson, Mark T.
    Jackson, Graham H.
    Morgan, Gareth J.
    Owen, Roger G.
    HAEMATOLOGICA, 2016, 101 (02) : E69 - E71
  • [47] Autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients over age 70.
    Borgono, Carla
    Trieu, Young
    Xu, Wei
    Pendergrast, Jacob
    Reece, Donna
    Trudel, Suzanne
    Mikhael, Joseph
    Kukreti, Vishal
    Chen, Christine I.
    BLOOD, 2007, 110 (11) : 314B - 314B
  • [48] Autologous stem cell transplantation (ASCT) in multiple myeloma (MM) -: The 1999 EBMT registry update.
    Björkstrand, B
    Svensson, H
    Goldschmidt, H
    Ljungman, P
    Apperley, J
    Remes, K
    Marcus, R
    Barbui, T
    Sureda, A
    Lenhoff, S
    de Laurenzi, A
    Bladé, J
    Ferrant, A
    Goldstone, AH
    Gahrton, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133
  • [49] NOVEL THERAPY INDUCTION IN A PATIENT WITH HIGH RISK MULTIPLE MYELOMA FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): A CASE REPORT
    Toolan, S.
    Bugler, J.
    Lane, W.
    Maglio, M.
    O'Gorman, P.
    Richardson, P. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S496 - S496
  • [50] High dose therapy (HDT) and autologous stem cell transplantation (ASCT) in multiple myeloma - A systematic review of the published literature.
    Simnett, S
    Stewart, L
    Sweetenham, JW
    Morgan, GJ
    Johnson, PWM
    BLOOD, 1997, 90 (10) : 4581 - 4581
12345